Ostatní
Návod 
Phreesia, Inc.
PHR
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.3B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
0%
ROA
0%
PE
-136
PS
2
Cena 1R
15-33
⌀ Cena
23.97
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
11-03-2026
Poslední dividenda
Profil
Phreesia, Inc. poskytuje integrovaný software a platformu založenou na SaaS pro zdravotnictví ve Spojených státech a Kanadě. Jeho platforma Phreesia nabízí soubor řešení pro řízení procesu přijímání pacientů, stejně jako integrované platební řešení pro zpracování plateb pacientů. Společnost využívá svou platformu v celé řadě způsobů, jako je Phreesia Mobile, mobilní zařízení pro pacienty; Phreesia Dashboard, webový řídicí panel pro klienty zdravotnických služeb; PhreesiaPads, což jsou samoobslužné přijímací tablety; a příchozí Kiosky, které jsou kiosky na místě. Platforma Phreesia také poskytuje registrační řešení pro automatizaci samoregistrace pacientů, řešení výnosového cyklu, které nabízí procesy ověřování pojištění, aplikace pro platby v místě prodeje a nástroje odhadu nákladů, řešení přístupu, které nabízí systém plánování schůzek pro online schůzky, připomenutí a sledování odkazů, a řešení v oblasti věd o živé přírodě pro poskytování cíleného a klinicky relevantního marketingového obsahu pacientům. Kromě toho nabízí platforma Phreesia společnosti řešení klinické podpory, která shromažďuje údaje o klinickém příjmu a výsledcích hlášených pacientek (PRO) pro přibližně 25 specialit a umožňuje klientům zdravotnických služeb komunikovat se svými pacienty prostřednictvím průzkumů, oznámení, textových a e-mailových zpráv a zdravotnických kampaní; a podpůrné moduly pro COVID-19 pro řízení dodávání vakcíny proti COVID-19 a identifikaci pacientů váhajících s vakcínou, screening sebehlášených rizikových faktorů COVID-19, umožňující bezkontaktní odbavení při návštěvách v osobě a sběr informací o příjmu během návštěv telezdravotnictví. Slouží pacientům, specializovaným praktikám, multispecializovaným skupinám a zdravotnickým systémům i farmaceutickým, zdravotnickým a biotechnologickým společnostem. Společnost byla založena v roce 2005 a sídlí v Raleigh v Severní Karolíně.
Sektor
Healthcare
Odvětví
Medical - Healthcare Information Services
Počet zaměstnanců
2082
Založení
2019-07-18
Podobné společnosti
$ 7.55
+ $ 0.02
$ 18.29
+ $ 0.51
$ 26.30
+ $ 0.37
$ 36.26
+ $ 0.58
$ 67.06
+ $ 2.06
$ 3.04
- $ 0.08
$ 11.02
+ $ 0.10
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 480.6 | 480.6 | 419.8 | 356.3 | 280.9 | 213.2 | 148.7 | 124.8 | 99.9 | 79.8 | |
| Cost of Revenues | 71.4 | 71.4 | 134.9 | 124.0 | 109.3 | 81.4 | 52.4 | 44.7 | 37.0 | 29.8 | |
| Gross Profit | 409.2 | 409.2 | 284.9 | 232.3 | 171.6 | 131.8 | 96.3 | 80.1 | 62.9 | 50.1 |
| Revenue | 4-2026 | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 127.1 | 120.3 | 117.3 | 115.9 | 109.7 | 106.8 | 102.1 | 101.2 | 95.0 | 91.6 | |
| Cost of Revenues | -42.4 | 38.0 | 37.6 | 38.1 | 33.6 | 34.5 | 32.8 | 34.0 | 31.8 | 30.9 | |
| Gross Profit | 169.4 | 82.3 | 79.6 | 77.9 | 76.1 | 72.3 | 69.3 | 67.2 | 63.2 | 60.7 |
| Operating Income | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 91.2 | 52.3 | 22.6 | 18.6 | 14.3 | 11.4 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 231.6 | 175.1 | 83.4 | 62.8 | 46.4 | 43.6 | |
| Depreciation & Amortization | 42.9 | 0.0 | 27.9 | 30.5 | 28.8 | 21.3 | 15.9 | 13.9 | 11.6 | 9.6 | |
| Total Operating Expenses | 301.6 | 301.6 | 343.0 | 368.8 | 348.2 | 248.7 | 122.0 | 95.4 | 72.4 | 64.6 | |
| Operating Income | 107.6 | 107.6 | -58.1 | -136.5 | -176.6 | -116.8 | -25.7 | -12.0 | -9.5 | -14.6 |
| Operating Income | TTM | 4-2026 | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Depreciation & Amortization | 21.2 | 7.5 | 7.4 | 6.9 | 6.9 | 7.1 | 7.5 | 6.9 | 8.5 | 7.5 | ||
| Total Operating Expenses | 60.8 | 78.6 | 81.1 | 81.2 | 83.7 | 86.1 | 86.5 | 86.6 | 92.8 | 92.7 | ||
| Operating Income | 108.7 | 3.7 | -1.5 | -3.3 | -7.6 | -13.8 | -17.2 | -19.4 | -29.6 | -32.0 |
| Net Income | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 6.0 | 2.2 | 2.7 | 4.1 | 2.5 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | -3.8 | -7.0 | 2.3 | 1.9 | 1.4 | 1.2 | -1.6 | -2.4 | 3.5 | 3.6 | |
| Other Expense | -116.5 | -116.5 | 2.3 | 1.1 | 0.9 | -1.2 | -1.6 | -10.1 | -2.1 | 0.0 | |
| IBT | -8.9 | -8.9 | -55.8 | -135.3 | -175.7 | -118.0 | -27.2 | -22.1 | -15.1 | -18.2 | |
| Income Tax Expense | 11.2 | 11.2 | 2.7 | 1.5 | 0.5 | 0.2 | 0.0 | -1.8 | -2.1 | 4.2 | |
| Net Income | -20.2 | -20.2 | -58.5 | -136.9 | -176.1 | -118.2 | -27.3 | -20.3 | -15.1 | -18.2 |
| Net Income | TTM | 4-2026 | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 3.6 | 1.2 | 1.0 | 0.2 | 0.6 | 0.6 | 0.7 | 0.8 | 0.8 | 1.0 | ||
| Interest Expense | -5.5 | 0.8 | 0.4 | 0.4 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | ||
| Other Expense | -119.0 | 1.4 | 0.9 | 0.1 | 2.2 | -0.1 | 0.0 | 0.2 | -0.9 | 0.5 | ||
| IBT | -10.3 | 5.1 | -0.6 | -3.2 | -5.4 | -14.0 | -17.3 | -19.2 | -30.4 | -31.6 | ||
| Income Tax Expense | 10.9 | 0.9 | -1.2 | 0.7 | 1.0 | 0.4 | 0.8 | 0.5 | 0.2 | 0.4 | ||
| Net Income | -21.2 | 4.3 | 0.7 | -3.9 | -6.4 | -14.4 | -18.0 | -19.7 | -30.6 | -31.9 |
| Per Share Data | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $-3.36 | $-2.37 | $-0.69 | $-1.00 | $-8.16 | $-11.82 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $-3.36 | $-2.37 | $-0.69 | $-1.00 | $-8.16 | $-11.82 | |
| Shares Outstanding | 59.7 | 59.7 | 57.6 | 54.6 | 52.4 | 49.9 | 39.5 | 20.3 | 1.8 | 1.5 | |
| Diluted Shares Outstanding | 61.5 | 61.5 | 57.6 | 54.6 | 52.4 | 49.9 | 39.5 | 20.3 | 1.8 | 1.5 |
| Per Share Data | TTM | 4-2026 | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Shares Outstanding | 59.7 | 59.5 | 59.3 | 58.9 | 58.3 | 57.9 | 57.5 | 56.7 | 54.6 | 55.3 | ||
| Diluted Shares Outstanding | 61.5 | 61.5 | 59.3 | 58.9 | 58.3 | 57.9 | 57.5 | 56.7 | 54.6 | 55.3 |
| Current Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 87.5 | 84.2 | 87.5 | 176.7 | 313.8 | 218.8 | 90.3 | 1.5 | 10.5 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 87.5 | 84.2 | 87.5 | 176.7 | 313.8 | 218.8 | 90.3 | 1.5 | 10.5 | |
| Accounts Receivable | 64.9 | 73.6 | 64.9 | 51.4 | 40.3 | 29.1 | 22.0 | 16.1 | 12.3 | |
| Inventory | 0.0 | 0.0 | 0.8 | 1.1 | 1.6 | 8.9 | 6.9 | 1.7 | 1.6 | |
| Other Current Assets | 42.5 | 45.4 | 42.5 | 33.3 | 30.6 | 15.5 | 12.4 | 13.6 | 11.5 | |
| Total Current Assets | 194.9 | 203.3 | 195.7 | 262.4 | 386.3 | 272.3 | 131.5 | 32.9 | 36.0 |
| Current Assets | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 98.3 | 90.9 | 84.2 | 81.7 | 81.8 | 79.5 | 87.5 | 103.4 | 127.7 | 149.8 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 98.3 | 90.9 | 84.2 | 81.7 | 81.8 | 79.5 | 87.5 | 103.4 | 127.7 | 149.8 | |
| Accounts Receivable | 76.8 | 108.1 | 73.6 | 96.5 | 61.3 | 66.3 | 64.9 | 57.4 | 53.9 | 52.9 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 0.0 | 0.0 | 0.8 | 0.8 | 0.9 | |
| Other Current Assets | 47.5 | 16.4 | 45.4 | 11.4 | 37.0 | 44.4 | 42.5 | 37.7 | 36.8 | 36.5 | |
| Total Current Assets | 222.6 | 215.4 | 203.3 | 189.6 | 180.9 | 190.1 | 194.9 | 199.2 | 219.2 | 240.1 |
| Long-Term Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 17.2 | 25.1 | 17.2 | 22.2 | 37.0 | 29.3 | 14.5 | 14.2 | 13.2 | |
| Goodwill | 75.8 | 75.8 | 75.8 | 33.7 | 33.6 | 8.3 | 0.3 | 0.3 | 0.0 | |
| Intangible Assets | 77.8 | 80.9 | 77.8 | 46.6 | 30.4 | 13.2 | 9.9 | 9.3 | 6.7 | |
| Long-Term Investments | 46.1 | 0.0 | 0.0 | 0.0 | 0.0 | 1.2 | 1.6 | 0.0 | 0.0 | |
| Other Long-Term Assets | -41.5 | 3.3 | 3.9 | 5.0 | 6.6 | 1.7 | 0.2 | 2.7 | 1.3 | |
| Total Long-Term Assets | 176.2 | 185.1 | 174.6 | 107.6 | 108.1 | 54.4 | 27.2 | 26.4 | 21.2 | |
| Total Assets | 371.1 | 388.4 | 370.3 | 370.1 | 494.5 | 326.7 | 158.8 | 59.3 | 57.1 |
| Long-Term Assets | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 24.8 | 24.8 | 25.1 | 28.7 | 22.8 | 23.0 | 17.2 | 20.3 | 23.0 | 26.6 | |
| Goodwill | 75.8 | 75.8 | 75.8 | 75.8 | 75.8 | 75.8 | 75.8 | 75.5 | 40.6 | 33.7 | |
| Intangible Assets | 26.4 | 80.8 | 80.9 | 29.0 | 79.7 | 79.0 | 77.8 | 76.8 | 54.2 | 49.2 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 46.1 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 57.3 | 3.6 | 3.3 | 52.6 | 3.0 | 4.1 | -41.5 | 2.8 | 3.4 | 4.2 | |
| Total Long-Term Assets | 186.0 | 185.0 | 185.1 | 186.1 | 181.3 | 182.0 | 176.2 | 175.4 | 121.2 | 113.7 | |
| Total Assets | 408.6 | 400.4 | 388.4 | 375.7 | 362.2 | 372.1 | 371.1 | 374.6 | 340.4 | 353.9 |
| Current Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 8.5 | 5.6 | 8.5 | 10.8 | 5.1 | 4.4 | 6.0 | 4.2 | 2.2 | |
| Short-Term Debt | 6.4 | 9.0 | 6.4 | 6.1 | 7.1 | 6.0 | 2.3 | 2.0 | 2.8 | |
| Other Current Liabilities | 71.1 | 64.1 | 68.0 | 42.9 | 39.7 | 33.8 | 21.6 | 15.3 | 15.1 | |
| Current Liabilities | 110.1 | 114.0 | 110.1 | 79.0 | 68.4 | 55.0 | 35.4 | 27.9 | 25.0 |
| Current Liabilities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 6.5 | 3.2 | 5.6 | 15.9 | 7.0 | 6.7 | 8.5 | 10.9 | 7.9 | 7.6 | |
| Short-Term Debt | 0.0 | 9.3 | 9.0 | 0.0 | 8.2 | 8.3 | 6.4 | 7.3 | 7.5 | 7.7 | |
| Other Current Liabilities | 71.7 | 63.9 | 64.1 | 69.2 | 63.5 | 67.4 | 68.0 | 53.8 | 50.0 | 48.1 | |
| Current Liabilities | 105.1 | 110.7 | 114.0 | 109.2 | 102.0 | 108.3 | 110.1 | 98.4 | 84.9 | 83.0 |
| Long-Term Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 2.0 | 8.8 | 5.5 | 6.1 | 8.7 | 8.4 | 21.5 | 30.3 | 20.1 | |
| Capital Leases | 3.5 | 15.9 | 8.8 | 1.3 | 15.8 | 3.0 | 4.4 | 4.3 | 2.3 | |
| Def. Tax Liability | 1.0 | 0.5 | 0.3 | 1.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 119.6 | 123.6 | 118.9 | 82.2 | 77.2 | 63.4 | 56.9 | 270.2 | 224.8 |
| Long-Term Liabilities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 4.8 | 6.6 | 8.8 | 11.1 | 8.4 | 9.2 | 5.5 | 7.2 | 16.5 | 13.9 | |
| Capital Leases | 0.2 | 1.4 | 15.9 | 0.8 | 16.5 | 7.2 | 3.5 | 14.3 | 15.8 | 14.6 | |
| Def. Tax Liability | 0.6 | 0.6 | 0.5 | 0.4 | 0.4 | 0.3 | 1.0 | 0.2 | 0.2 | 0.1 | |
| Total Liabilities | 110.6 | 118.2 | 123.6 | 121.1 | 110.9 | 119.3 | 119.6 | 110.0 | 93.4 | 90.2 |
| Total Common Equity | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.4 | 0.4 | 0.0 | 0.0 | |
| Retained Earnings | -743.0 | -801.5 | -743.0 | -606.1 | -429.9 | -311.8 | -284.5 | -211.0 | -167.7 | |
| Comprehensive Income | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | -158.8 | -27.9 | -20.3 | |
| Total Common Equity | 251.4 | 264.8 | 251.4 | 287.8 | 417.3 | 263.3 | 101.9 | -211.0 | -167.7 |
| Total Common Equity | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | |
| Retained Earnings | -804.8 | -805.4 | -801.5 | -795.1 | -780.7 | -762.7 | -743.0 | -712.3 | -680.4 | -643.6 | |
| Comprehensive Income | 0.1 | 0.4 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 298.0 | 282.2 | 264.8 | 254.6 | 251.3 | 252.7 | 251.4 | 264.6 | 247.0 | 263.6 |
| Other | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 12.0 | 17.8 | 12.0 | 9.2 | 15.8 | 14.3 | 23.9 | 32.3 | 22.9 | |
| Book Value | 251.4 | 264.8 | 251.4 | 287.8 | 417.3 | 263.3 | 101.9 | -211.0 | -167.7 |
| Other | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 298.0 | 282.2 | 264.8 | 254.6 | 251.3 | 252.7 | 251.4 | 264.6 | 247.0 | 263.6 |
| Cash Flow From Operating Activities | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -136.9 | 2.3 | -58.5 | -136.9 | -176.1 | -118.2 | -27.3 | -20.3 | -15.1 | -18.2 | |
| Depreciation & Amortization | 29.7 | 31.5 | 27.9 | 29.5 | 25.3 | 21.3 | 15.9 | 13.9 | 11.6 | 9.6 | |
| Stock-Based Compensation | 71.6 | 67.5 | 67.0 | 71.7 | 58.8 | 36.1 | 13.5 | 6.2 | 1.4 | 0.8 | |
| Change Working Capital | -1.6 | 0.0 | -6.5 | -1.6 | -3.9 | -18.6 | -4.1 | -5.8 | -3.5 | -6.3 | |
| Change In Accounts Receivable | -11.2 | -23.4 | -8.8 | -11.2 | -11.1 | -10.2 | -6.6 | -5.9 | -3.8 | -3.4 | |
| Change In Accounts Payable | -2.0 | 5.3 | -3.2 | -2.0 | 4.8 | 2.9 | -3.8 | 0.0 | 2.0 | -2.1 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.6 | 3.4 | -2.4 | 1.6 | |
| Other Non-cash Items | 4.9 | -9.1 | 2.3 | 4.7 | 5.4 | 4.4 | 4.9 | 7.5 | 1.4 | 2.3 | |
| Cash from Operations | -32.1 | 0.0 | 0.0 | 0.0 | -90.1 | -74.7 | 2.9 | 0.8 | -2.1 | -11.1 |
| Cash Flow From Operating Activities | 4-2026 | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 2.3 | 4.3 | 0.7 | -3.9 | -6.4 | -14.4 | -18.0 | -19.7 | -30.6 | -31.9 | |
| Depreciation & Amortization | 9.7 | 7.5 | 7.4 | 6.9 | 6.8 | 7.1 | 7.3 | 6.9 | 8.5 | 7.5 | |
| Stock-Based Compensation | 18.0 | 16.0 | 16.2 | 17.2 | 17.2 | 16.5 | 16.4 | 16.8 | 17.9 | 18.0 | |
| Change Working Capital | 0.0 | -12.9 | -8.1 | -6.2 | 0.0 | -5.6 | 4.5 | -5.3 | -0.6 | -0.9 | |
| Change In Accounts Receivable | -8.6 | -11.5 | -1.8 | -1.5 | -2.3 | -10.1 | 5.0 | -1.4 | -7.8 | -1.0 | |
| Change In Accounts Payable | 3.6 | 1.3 | 2.1 | -1.7 | -8.4 | 6.9 | 1.2 | -2.9 | -0.8 | 1.2 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.2 | -1.3 | |
| Other Non-cash Items | 15.5 | 0.6 | 0.2 | 0.8 | -1.4 | 2.2 | 0.8 | 35.3 | 2.0 | 1.0 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Investing Activities | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -25.1 | -11.1 | -8.7 | -5.8 | -26.2 | -30.8 | -18.6 | -12.3 | -9.8 | -12.0 | |
| Acquisitions | -14.6 | -153.2 | 0.0 | -14.6 | 0.0 | -34.4 | -6.5 | 0.0 | -1.2 | 0.0 | |
| Investments | 0.0 | 15.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | -13.9 | 0.0 | 0.0 | 0.0 | -21.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -39.7 | 0.0 | 0.0 | 0.0 | -26.2 | -65.2 | -25.1 | -12.3 | -11.0 | -12.0 |
| Cash Flow From Investing Activities | 4-2026 | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -2.6 | -3.3 | -1.8 | -3.5 | -2.8 | -0.6 | -4.4 | -5.4 | -7.9 | -5.3 | |
| Acquisitions | -153.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | -10.4 | |
| Investments | 15.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Financing Activities | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -6.7 | 0.0 | 0.0 | 0.0 | -5.7 | -4.3 | -23.3 | -40.6 | -10.6 | -23.5 | |
| Debt Issued | 9.5 | 17.8 | 5.8 | 2.8 | -0.9 | 5.7 | 13.8 | 32.2 | 20.0 | 46.4 | |
| Issuance of Common Stock | 8.2 | 0.0 | 0.0 | 0.0 | 0.0 | 245.8 | 174.8 | 130.8 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | -12.2 | -19.4 | -9.0 | 0.0 | 31.7 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -15.0 | 0.0 | 0.0 | |
| Other Financing Activities | -16.4 | 0.0 | 0.0 | 0.0 | -20.0 | 2.4 | -0.8 | -6.6 | 14.8 | 54.8 | |
| Cash from Financing | -17.4 | 0.0 | 0.0 | 0.0 | -20.4 | 235.0 | 150.7 | 100.3 | 4.2 | 31.3 |
| Cash Flow From Financing Activities | 4-2026 | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 0.0 | 4.8 | -11.1 | -1.9 | 6.7 | -5.4 | -1.0 | 5.5 | -2.5 | -1.3 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 12.2 | -1.5 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash position | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -89.2 | 0.0 | -3.3 | -89.2 | -137.1 | 95.0 | 128.5 | 88.8 | -9.0 | 8.2 | |
| Closing Cash Balance | 87.5 | 0.0 | 84.2 | 87.5 | 176.7 | 313.8 | 218.8 | 90.3 | 1.5 | 10.5 |
| Cash position | 4-2026 | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 0.0 | 8.1 | 7.4 | 6.7 | 2.5 | -0.1 | 2.3 | -8.0 | -15.8 | -24.3 | |
| Closing Cash Balance | 0.0 | 106.4 | 98.3 | 90.9 | 84.2 | 81.7 | 81.8 | 79.5 | 87.5 | 103.4 |
| Free Cash Flow | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -57.2 | 67.7 | 8.3 | -57.5 | -116.3 | -105.5 | -15.7 | -11.5 | -12.0 | -23.1 | |
| Real Free Cash Flow | -128.8 | 0.3 | -58.7 | -129.2 | -175.1 | -141.7 | -29.2 | -17.7 | -13.4 | -23.9 |
| Free Cash Flow | 4-2026 | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 31.1 | 12.2 | 13.1 | 7.5 | 9.2 | 5.2 | 3.7 | -6.3 | -10.7 | -11.6 | |
| Real Free Cash Flow | 13.1 | -3.8 | -3.2 | -9.8 | -8.0 | -11.4 | -12.8 | -23.2 | -28.6 | -29.6 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -135.6 | -39.7 | 120.8 |
| P/S | 1.6 | 7.3 | 9.7 |
| P/B | 2.4 | 5.6 | 738.2 |
| P/FCF | -29.6 | -31.9 | 111.3 |
| Market cap | $1.3 | $1.4 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 9 % | 0 % |
| Debt to Income | -23.6 % | -53.6 % | 0 % |
| Debt to Free cash flow | -131.1 % | -508.1 % | 0 % |
| Interest expense percentage | -3.5 % | -5.2 % | 18.1 % |
| Current ratio | 2.1 | 3.3 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -6.8 % | -18.5 % | 0 % |
| ROA | -4.9 % | -18.4 % | 0 % |
| CapEx to Revenue | 2.4 % | 9.2 % | 2.4 % |
| RaD to Revenue | 0 % | 19.8 % | 0 % |
| ROEM | 230,831.4 | 131979 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 68.2 % | 63.6 % | 89.7 % |
| Operating margin | -1.9 % | -25.3 % | 37.4 % |
| Net margin | -1.2 % | -27.5 % | 37.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | -0.4 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 61.5 mil | 44.8 mil |
| Employee count | 2.1 tis | 1.4 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
